{
    "2019-10-14": [
        [
            {
                "time": "2019-10-14",
                "original_text": "机构、高管争相买入的业绩暴增股 3股机构已抢筹上亿！多股已被大股东偷偷增持",
                "features": {
                    "keywords": [
                        "机构买入",
                        "高管增持",
                        "业绩暴增",
                        "抢筹上亿",
                        "大股东增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-10-14",
                "original_text": "前三季净利预增30.45%-41.42% 贝达药业涨停",
                "features": {
                    "keywords": [
                        "净利预增",
                        "贝达药业",
                        "涨停"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-14",
                "original_text": "贝达药业早盘最高涨幅超8% 前三季盈利超1.9亿",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "早盘涨幅",
                        "盈利超1.9亿"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-14",
                "original_text": "A股异动 | 贝达药业续涨逾9% 料前三季度净利增30.45%至41.42%",
                "features": {
                    "keywords": [
                        "A股异动",
                        "贝达药业",
                        "续涨逾9%",
                        "净利增"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-14",
                "original_text": "主力产品销售放量 贝达药业前三季度净利预增三成多",
                "features": {
                    "keywords": [
                        "主力产品",
                        "销售放量",
                        "贝达药业",
                        "净利预增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2019-10-14",
                "original_text": "贝达药业：预计前三季净利增长30.45%-41.42%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利增长",
                        "前三季"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}